Progressive Hematology And Oncology Pllc is categorized under Oncologists in Brooklyn, NY and active since 2013.
Progressive Hematology And Oncology Pllc was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Mark Sonnenschine at the company’s single location by writing to 1120 East 32nd St, Brooklyn, New York NY 11210 or by phoning (718) 283-4232. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Progressive Hematology And Oncology Pllc |
| Contact Person: | Mark Sonnenschine |
| Address: | 1120 East 32nd St, Brooklyn, New York 11210 |
| Phone Number: | (718) 283-4232 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Progressive Hematology And Oncology Pllc was started in 2013 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mark Sonnenschine for inquiries that concern Progressive Hematology And Oncology Pllc by calling the company number (718) 283-4232, as your correspondence is most welcome. Additionally, the physical location of the single location of Progressive Hematology And Oncology Pllc can be found at the coordinates 40.624253,-73.944618 as well as the street address 1120 East 32nd St in Brooklyn, New York 11210.
For its online presence, you may visit Progressive Hematology And Oncology Pllc’s website at and engage with its social media outlets through on Twitter and on Facebook.